Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MDXG stock hub

MiMedx Group, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MDXGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

536.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MDXG

In the news

Latest news · MDXG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E2,144.8

P25 12.3P50 18.4P75 33.1

Trailing P/E17.9

P25 14.9P50 23.2P75 38.5

ROE13.8

P25 -105.6P50 -46.5P75 -3.1

ROIC26.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MDXG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001376339
Company name	MiMedx Group, Inc.
Country	United States
Country code	US
Cusip	602496101
Employees	808
Employees Change	-29%
Employees Change Percent	-3.46
Enterprise value	$394M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6024961012
Last refreshed	2026-05-10
Market cap	$536.2M
Market cap category	Small-Cap
Price	$3.6
Price currency	USD
Rev Per Employee	481,950.5x
Sector	Healthcare
Sic	3841
Symbol	MDXG
Website	https://www.mimedx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.72%
EV Earnings	12.84x
EV Sales Forward	1.25x
EV/EBIT	9.95x
EV/EBITDA	7.45x
EV/FCF	5.68x
EV/Sales	1.01x
FCF yield	12.93%
Forward P/E	2,144.82x
P/B ratio	2.21x
P/E ratio	17.91x
P/S ratio	1.38x
PE Ratio3 Y	21.76x
PS Forward	1.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.17%
EBITDA Margin	13.58%
FCF margin	17.81%
Gross margin	81.04%
Gross Profit	$315.6M
Gross Profit Growth	9.3%
Gross Profit Growth Q	-41.91%
Gross Profit Growth3 Y	11.15%
Gross Profit Growth5 Y	8.75%
Net Income	$30.7M
Net Income Growth	-23.61%
Net Income Growth Years	1%
Pretax Margin	10.87%
Profit Margin	7.88%
Profit Per Employee	$37,989
Profitable Years	3
ROA	8.54
Roa5y	6.37
ROCE	14.99
ROE	13.77
Roe5y	14.29
ROIC	26.87
Roic5y	16.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.55%
Cagr15y	8.91%
Cagr1y	-48.45%
Cagr3y	-14.4%
Cagr5y	-18.38%
EPS Growth	-25.95
EPS Growth Years	1
FCF Growth	7.36%
FCF Growth Q	-73.41%
OCF Growth	7.73%
OCF Growth Q	-64.54%
OCF Growth10 Y	17.88%
Revenue Growth	10.51x
Revenue Growth Q	-33.12x
Revenue Growth Years	4x
Revenue Growth3 Y	11.54x
Revenue Growth5 Y	9.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.34
Assets	$308.7M
Cash	$159.8M
Current Assets	$240.3M
Current Liabilities	$44.6M
Debt	$17.6M
Debt EBITDA	$0.32
Debt Equity	$0.07
Debt FCF	$0.25
Equity	$242.9M
Interest Coverage	23.19
Liabilities	$65.7M
Long Term Assets	$68.4M
Long Term Liabilities	$21.2M
Net Cash	$142.2M
Net Cash By Market Cap	$26.52
Net Cash Growth	61.98%
Net Debt EBITDA	$-2.69
Net Debt Equity	$-0.59
Net Debt FCF	$-2.05
Tangible Book Value	$210.4M
Tangible Book Value Per Share	$1.41
WACC	12.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.39
Inventory Turnover	2.94
Net Working Capital	$37.5M
Quick ratio	4.62
Working Capital	$195.8M
Working Capital Turnover	$2.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-49.22%
1Y total return	-48.42%
200-day SMA	5.96
3Y total return	-37.28%
50-day SMA	3.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.78%
All Time High	18.25
All Time High Change	-80.27%
All Time High Date	2018-01-29
All Time Low	0.35
All Time Low Change	928.57%
All Time Low Date	2009-09-04
ATR	0.19
Beta	1.46
Beta1y	0.67
Beta2y	0.54
Ch YTD	-46.82
High	3.73
High52	7.99
High52 Date	2025-07-31
High52ch	-54.94%
Low	3.6
Low52	3.03
Low52 Date	2026-04-29
Low52ch	19.01%
Ma50ch	-9.09%
Premarket Change Percent	1.08
Premarket Price	$3.73
Premarket Volume	806
Price vs 200-day SMA	-39.62%
RSI	47.26
RSI Monthly	35.43
RSI Weekly	25.04
Sharpe ratio	-1.39x
Sortino ratio	-1.76
Total Return	-0.31%
Tr YTD	-46.82
Tr15y	260%
Tr1m	-6.74%
Tr1w	-2.17%
Tr3m	-30.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$7
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	64,040,000x
Earnings Revenue Estimate Growth	-27.4x
Operating Income	$39.6M
Operating Income Growth	-27.11
Operating margin	10.17
Price target	$8.83
Price Target Change	$145
Price Target Change Top	$94.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,986,736%
Float Percent	79.21%
Net Borrowing	-1,125,000
Shares Insiders	1.86%
Shares Institutions	52.75%
Shares Out	148,945,731
Shares Qo Q	-1.16%
Shares Yo Y	0.31%
Short Float	6.31%
Short Ratio	6.12
Short Shares	5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$58.9M
Average Volume	1,964,269.35x
Bv Per Share	1.63
CAPEX	$-1.2M
Ch10y	-49.22
Ch15y	260
Ch1m	-6.74
Ch1w	-2.17
Ch1y	-48.42
Ch3m	-30.1
Ch3y	-37.28
Ch5y	-63.78
Ch6m	-51.61
Change	-2.44%
Change From Open	-3.23
Close	3.69
Days Gap	0.81
Depreciation Amortization	13,295,000
Dollar Volume	6,360,314.4
Earnings Date	2026-04-29
Earnings Time	amc
EBIT	$39.6M
EBITDA	$52.9M
EPS	$0.2
F Score	6
FCF	$69.4M
FCF EV Yield	17.6x
FCF Per Share	$0.47
Financing CF	-5,119,000
Fiscal Year End	December
Founded	2,006
Goodwill	19,441,000
Graham Number	2.71625
Graham Upside	-24.55
Income Tax	$11.6M
Investing CF	-12,122,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	5.6
Ma150ch	-35.71%
Ma20	3.51
Ma20ch	2.59%
Net CF	53,342,000
Next Earnings Date	2026-07-29
Open	3.72
Optionable	Yes
P FCF Ratio	7.73
P OCF Ratio	7.6
Position In Range	0
Post Close	3.6
Postmarket Change Percent	0.28
Postmarket Price	$3.61
Ppne	4,756,000
Pre Close	3.69
Price Date	2026-05-08
Price EBITDA	$10.14
Ptbv Ratio	2.55
Relative Volume	0.9x
Revenue	389,416,000x
SBC By Revenue	2.68x
Share Based Comp	10,438,000
Tax By Revenue	2.98x
Tax Rate	27.47%
Tr6m	-51.61%
Us State	Georgia
Volume	1,766,754
Z Score	10.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MDXG pay a dividend?

Capital-return profile for this ticker.

Performance

MDXG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MDXG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+52.7%

Float: +79.2% of shares outstanding

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MDXG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-39.6%

50/200-day relationship not available

Beta (5Y)

1.46

More volatile than the market

Sharpe ratio

-1.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MDXG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MDXG stock rating?

MiMedx Group, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MDXG analysis?

The full report lives at /stocks/MDXG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MDXG?

The latest report frames MDXG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MDXG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.